Immediate start of hormonal contraceptives for contraception

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Lopez, Laureen M ^a   Newmann, S J ^b   Grimes, D A ^b   Nanda, K ^b   Schulz, K F ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL CYPIONATE PLUS MEDROXYPROGESTERONE ACETATE; ESTRADIOL VALERATE PLUS NORETHISTERONE ENANTATE; ETHINYLESTRADIOL PLUS ETONOGESTREL; ETHINYLESTRADIOL PLUS NORELGESTROMIN; ETHINYLESTRADIOL PLUS NORETHISTERONE; ETONOGESTREL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NOMEGESTROL ACETATE; NORELGESTROMIN; NORETHISTERONE ENANTATE; ORAL CONTRACEPTIVE AGENT;

ACNE; APPETITE; BILIARY TRACT DISEASE; BLEEDING; BREAKTHROUGH BLEEDING; BREAST DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA ANALYSIS; DRUG WITHDRAWAL; EMBASE; EMERGENCY CONTRACEPTION; HAIR DISEASE; HEADACHE; HORMONAL CONTRACEPTION; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDLINE; MENSTRUAL CYCLE; MOOD CHANGE; MUSCLE CRAMP; NAUSEA; PATIENT SATISFACTION; PELVIC INFLAMMATORY DISEASE; PYELONEPHRITIS; REVIEW; SIDE EFFECT; SPOTTING; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT; VAGINA RING; WEIGHT CHANGE;

EID: 44949176611     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006260.pub2     Document Type: Review

References (33)

1. Murthy 2005 {published data only} Murthy A, Creinin M, Harwood B, Schreiber C. Same-day initiation of the transdermal hormonal delivery system (contraceptive patch) versus traditional initiation methods. Contraception 2005;72:333-6.
2. Rickert 2007 {published data only} Rickert V, Tiezzi L, Lipshutz J, Leon J, Vaughan R, Westhoff C. Depo Now: preventing unintended pregnancies among adolescents and young adults. Journal of Adolescent Health 2007;40:22-8.
3. Westhoff 2003 {published data only} Westhoff C, Morroni C, Kerns J, Murphy PA. Bleeding patterns after immediate vs. conventional oral contraceptive initiation: a randomized, controlled trial. Fertility and Sterility 2003;79:322-9.
4. Westhoff 2005 {published data only} O'Connell KJ, Osborne LM, Westhoff C. Measured and reported weight change for women using a vaginal contraceptive ring vs. a low-dose oral contraceptive. Contraception 2005;72:323-7.
5. Schafer JE, Osborne LM, Davis AR, Westhoff C. Acceptability and satisfaction using Quick Start with the contraceptive vaginal ring versus an oral contraceptive. Contraception 2006;73:488-92.
6. *Westhoff C, Osborne LM, Schafer JE, Morroni C. Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive. Obstetrics & Gynecology 2005;106:89-96.
7. Westhoff 2007 {published data only} Westhoff C, Heartwell S, Edwards S, Zieman M, Cushman L, Robilotto C, et al.Initiation of oral contraceptives using a quick start compared with a conventional start. Obstetrics & Gynecology 2007;109:1270-6.
8. Paseková 2003 Paseková V, Chroust K. Occurrence of bleeding in women using combined hormonal contraceptives (ethinylestradiol 30 micrograms/norgestimte 250 micrograms in relation to regularity of administration and cycle start day. Ceská Gynekologie 2003;68:84-8.
9. Sitavarin 2003 Sitavarin S, Jaisamrarn U, Taneepanichskul S. A randomized trial on the impact of starting day on ovarian follicular activity in very low dose oral contraceptive pills users. Journal of the Medical Association of Thailand 2003;86:442-8.
10. Were 1997 Were EO, Kendall JZ, Nyongesa P. Randomized clinical trial to determine optimum initiation time of norgestrel-progestin only contraception in Eldoret Teaching Hospital, Kenya. East African Medical Journal 1997;74:103-7.
11. Yeshaya 1998 Yeshaya A, Orvieto R, Kaplan B, Dicker D, Bar-Hava I, Bar J, et al.Flexible starting schedule for oral contraception: effect on the incidence of breakthrough bleeding and compliance. European Journal of Contraception and Reproductive Health Care 1998;3:121-3.
12. Nanda 2006 Nanda K, Stanback J, Rountree RW, Cameron SB. Randomized trial of "Quick Start" versus advance provision of oral contraceptive pills in Nicaragua (abstract). Obstetrics & Gynecology 2006;107:50S.
13. Bracken 1990 Bracken MB. Oral contraception and congenital malformations in offspring: a review and meta-analysis of the prospective studies. Obstetrics & Gynecology 1990;76:552-7.
14. Deeks 2001 Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: EggerM, SmithGD, AltmanDG editor(s). Systematic Reviews in Health Care: Meta-analysis in Context. 2nd Edition. London: BMJ Publishing Group, 2001:285-312.
15. Higgins 2005 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. www.cochrane.dk/cochrane/handbook/hbook.htm (accessed 1 June 2005).
16. Kubba 1993 Kubba A, Guillebaud J. Combined oral contraceptives: acceptability and effective use. British Medical Bulletin 1993;49:140-57.
17. Lara-Torre 2002 Lara-Torre E, Schroeder B. Adolescent compliance and side effects with Quick Start initiation of oral contraceptive pills. Contraception 2002;66:81-5.
18. Lara-Torre 2004 Lara-Torre E. "Quick Start", an innovative approach to the combined oral contraceptive pill in adolescents. Is it time to make the switch?. Journal of Pediatric Adolescent and Gynecology 2004;17:65-7.
19. Moher 2001 Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Lancet 2001;357:1191-4.
20. Ortho-McNeil 2007 Ortho-McNeil Pharmaceutical. Ortho Evra prescribing information (USA). http://www.orthoevra.com/html/pevr/ full_prescribing.jsp? (accessed 20 June 2007).
21. Sackett 2000 Sackett DL, Strauss SE, Richardson WS, Rosenberg W, Haynes RB. Evidence-based Medicine: How to Practice and Teach EBM. Second Edition. New York: Churchill Livingstone, 2000.
22. Schulz 1995 Schulz KF, Chalmers I, Hayes RJ, Altman DG. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Journal of the American Medical Association 1995;273:408-12.
23. Schulz 2002a Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet 2002;359:614-8.
24. Schulz 2002b Schulz KF, Grimes DA. Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet 2002;359:781-5.
25. Schulz 2005 Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet 2005;365:1348- 53.
26. Stanback 1997 Stanback J, Thompson A, Hardee K, Janowitz B. Menstruation requirements: a significant barrier to contraceptive access in developing countries. Studies in Family Planning 1997;28:245-50.
27. Stanback 1999 Stanback J, Nutley T, Gitonga J, Qureshi Z. Menstruation requirement as a barrier to contraceptive access in Kenya. East African Medical Journal 1999;76:124-6.
28. Stanback 2003 Stanback J, Janowitz B. Provider resistance to advance provision of oral contaceptives in Africa. Journal of Family Planning and Reproductive Health Care 2003;29:35-6.
29. UNDP 2003 United Nations Department of Economic and Social Affairs Population Division. World Contraceptive Use 2003. http://www.un.org/esa/ population/publications/contraceptive2003/WallChart_CP2003_web.xls (accessed 07 November 2005).
30. Westhoff 2002 Westhoff C, Kerns J, Morroni C, Cushman L, Tiezzi L, Murphy P. Quick Start: a novel oral contraceptive initiation method. Contraception 2002;66:141-5.
31. WHO 2004 World Health Organization, Family and Community Health. Selected Practice Recommendations for Contraceptive Use. Second Edition. Geneva: World Health Organization, 2004.
32. Williams-Deane 1992 Williams-Deane M, Potter LS. Current oral contraceptive use instructions: an analysis of patient package inserts. Family Planning Perspectives 1992;24:111-5.
33. Wilson 1981 Wilson JG, Brent RL. Are female sex hormones teratogenic?. American Journal of Obstetrics and Gynecology 1981;141:567-80.